CIM
ZBH icon

Cambria Investment Management’s Zimmer Biomet ZBH Stock Holding History

Cambria Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,524
Closed -$286K – 484
2025
Q1 		$286K Hold
2,524
– – 0.02% 308
2024
Q4 		$267K Buy
+2,524
New +$271K 0.02% 350

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cambria Investment Management's ZBH Position: Q2 2025 in Review

Cambria Investment Management sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,524 shares — an estimated $286K sold.

Cambria Investment Management first reported a position in ZBH in Q4 2024 and held it in 2 quarters. The position peaked at $286K in Q1 2025. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Cambria Investment Management reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Cambria Investment Management sold 2,524 Zimmer Biomet shares in Q2 2025, an estimated $286K.
  • Cambria Investment Management first reported a position in Zimmer Biomet in Q4 2024 and held it in 2 quarters.
  • Cambria Investment Management's Zimmer Biomet position peaked at $286K in Q1 2025.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Cambria Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.